Sangamo Therapeutics Announces First Quarter 2026 Earnings Call

Click here to view

Careers
Clinical Trials
Contact

Science
Programs
Patients
Investors & Media
- Overview
- News Releases
- Events
- Presentations
- ESG
About

Science
Programs
Patients
Investors & Media
- Overview
- News Releases
- Events
- Presentations
- ESG
About

LinkedIn
Twitter

Presentation

ASGCT 2023

Strategic Formulation Development for AAV Delivered Gene Therapies – a Case Study

Download PDF

Sign up for email alerts

Company

Science
Programs
Collaborations
Patients
About
Careers
Contact

Latest

News Releases
Events
Science Presentations
Scientific Publications
Corporate Presentations

Resources

Pipeline
Clinical Trials
Legal Disclaimer
Privacy Policy

Social

LinkedIn
X

© 2026 Sangamo Therapeutics